Givaudan (OTCMKTS:GVDNY) Hits New 52-Week High – Should You Buy?

Givaudan SA (OTCMKTS:GVDNY – Get Free Report)’s stock price hit a new 52-week high on Monday. The company traded as high as $97.42 and last traded at $97.42, with a volume of 451 shares. The stock had previously closed at $95.09.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Jefferies Financial Group downgraded Givaudan from a “buy” rating to a “hold” rating in a research report on Tuesday, September 1st. Barclays upgraded Givaudan from an “equal weight” rating to an “overweight” rating in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Givaudan in a research report on Thursday, September 3rd. Citigroup reiterated a “neutral” rating on shares of Givaudan in a research note on Friday, September 25th. Finally, Sanford C. Bernstein assumed coverage on Givaudan in a report on Wednesday, July 22nd. They issued a “strong sell” rating for the company. Three investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold”.

View Our Latest Stock Report on GVDNY

Givaudan Stock Down 1.8%

The stock’s 50 day moving average price is $85.60 and its 200-day moving average price is $78.89.

About Givaudan

(Get Free Report)

Givaudan is a Swiss company that develops and produces flavors, fragrances and related ingredients for consumer and industrial products. Its solutions are used in a broad range of applications, including foods and beverages, fine fragrances, personal care products, household goods and oral care.

The company operates through two principal areas: Taste & Wellbeing, which provides flavors, taste-modulation solutions, natural extracts and functional ingredients; and Fragrance & Beauty, which develops fragrances, fragrance ingredients, cosmetic ingredients and active beauty solutions.

Recommended Stories

Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.